share_log

Ayala Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-I.B.F Management Ltd.(71.63%),Israel Biotech Fund II, L.P.(44.79%), etc.

Ayala Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-I.B.F Management Ltd.(71.63%),Israel Biotech Fund II, L.P.(44.79%)等

美股SEC公告 ·  2024/02/13 01:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息